MedPath

MEDVANTX, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

99

FDA:99

Drug Approvals

Fluoxetine

Approval Date
Aug 15, 2013
FDA

Cyclobenzaprine Hydrochloride

Approval Date
Jul 24, 2013
FDA

Citalopram

Approval Date
Jul 18, 2013
FDA

Ciprofloxacin

Approval Date
Jul 8, 2013
FDA

Alendronate Sodium

Approval Date
Jul 1, 2013
FDA

ATORVASTATIN CALCIUM

Approval Date
Jun 20, 2013
FDA

Amitriptyline Hydrochloride

Approval Date
May 30, 2013
FDA

Azithromycin

Approval Date
May 16, 2013
FDA

Metoprolol Tartrate

Approval Date
May 10, 2013
FDA

Meloxicam

Approval Date
Apr 25, 2013
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.